Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Barry

Showing results (351-360 of 1,132) with videos related to

Pageof 114
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1997
Susceptibility testing quality control studies with fosfomycin tromethamineP C Fuchs, A L Barry, S D Brown
Journal of Clinical Microbiology|February 18, 1998
Quality control limits for dilution and disk diffusion susceptibility tests of trovafloxacin against eight quality control strainsP C Fuchs, A L Barry, S D Brown
Journal of Chemotherapy (Florence, Italy)|March 10, 1998
Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacinP C Fuchs, A L Barry, S D Brown
The American Journal of the Medical Sciences|May 20, 1999
New treatment strategies in patients with impaired left ventricular systolic function. Part II: Treatment of moderate to severe cardiac dysfunctionJ C Rozo, W L Barry, G A Stouffer
Antimicrobial Agents and Chemotherapy|September 19, 2000
Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicatorP C Fuchs, A L Barry, S D Brown
Diagnostic Microbiology and Infectious Disease|October 12, 2000
Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro testsP C Fuchs, A L Barry, S D Brown
Diagnostic Microbiology and Infectious Disease|January 9, 2001
In vitro activity of gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteriaP C Fuchs, A L Barry, S D Brown
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centersA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|April 17, 2001
Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight mediaA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|January 18, 2002
Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory StandardsPeter C Fuchs, Arthur L Barry, Steven D Brown
Pageof 114

Showing results (351-360 of 1,132) with videos related to

Sort By:
Pageof 114
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1997
Susceptibility testing quality control studies with fosfomycin tromethamineP C Fuchs, A L Barry, S D Brown
Journal of Clinical Microbiology|February 18, 1998
Quality control limits for dilution and disk diffusion susceptibility tests of trovafloxacin against eight quality control strainsP C Fuchs, A L Barry, S D Brown
Journal of Chemotherapy (Florence, Italy)|March 10, 1998
Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacinP C Fuchs, A L Barry, S D Brown
The American Journal of the Medical Sciences|May 20, 1999
New treatment strategies in patients with impaired left ventricular systolic function. Part II: Treatment of moderate to severe cardiac dysfunctionJ C Rozo, W L Barry, G A Stouffer
Antimicrobial Agents and Chemotherapy|September 19, 2000
Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicatorP C Fuchs, A L Barry, S D Brown
Diagnostic Microbiology and Infectious Disease|October 12, 2000
Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro testsP C Fuchs, A L Barry, S D Brown
Diagnostic Microbiology and Infectious Disease|January 9, 2001
In vitro activity of gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteriaP C Fuchs, A L Barry, S D Brown
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centersA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|April 17, 2001
Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight mediaA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|January 18, 2002
Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory StandardsPeter C Fuchs, Arthur L Barry, Steven D Brown
Pageof 114